|
|
Xceed Capital Limited - Comparative Business Analysis Snapshot
Business Description
Xceed Capital Limited Formerly known as Xceed Biotechnology Limited. The Group's principal activities are manufacturing, marketing and selling of Boron Molecular's range of organo-boron compounds and identifying investment opportunities. Its segment includes chemical which is a supplier of organo-boron compounds for the pharmaceutical markets. It offers products and services to research organizations and pharmaceutical companies. The Group operates in Australia.
Competitor Analysis
This analysis compares Xceed Capital Limited with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
